0000000000924359
AUTHOR
Andrej Schmidt
showing 5 related works from this author
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy.
2021
Summary Background Among asymptomatic patients with severe carotid artery stenosis but no recent stroke or transient cerebral ischaemia, either carotid artery stenting (CAS) or carotid endarterectomy (CEA) can restore patency and reduce long-term stroke risks. However, from recent national registry data, each option causes about 1% procedural risk of disabling stroke or death. Comparison of their long-term protective effects requires large-scale randomised evidence. Methods ACST-2 is an international multicentre randomised trial of CAS versus CEA among asymptomatic patients with severe stenosis thought to require intervention, interpreted with all other relevant trials. Patients were eligib…
One-year results from the DETOUR I trial of the PQ Bypass DETOUR System for percutaneous femoropopliteal bypass
2019
The objective of this study was to evaluate the 1-year safety and effectiveness outcomes associated with the PQ Bypass DETOUR System (PQ Bypass, Milpitas, Calif) for the percutaneous bypass of long-segment femoropopliteal occlusive disease.This prospective, single-arm, multicenter trial enrolled patients with long-segment femoropopliteal arterial disease. The DETOUR System percutaneously deploys modular stent grafts to bypass femoropopliteal lesions through a transvenous route. Eligible patients included those with TransAtlantic Inter-Society Consensus C and D lesions100 mm in length. The primary safety end point was the major adverse event (MAE) rate through 1 month, defined as the composi…
Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System
2021
Purpose: This study investigated the 2-year safety and effectiveness of the PQ Bypass DETOUR system as a percutaneous femoropopliteal bypass. Materials and Methods: Seventy-eight patients with 82 long-segment femoropopliteal lesions were enrolled in this prospective, single-arm, multicenter study. The DETOUR system deployed Torus stent grafts directed through a transvenous route. Eligible patients included those with lesions of >10 cm and average of 371±55 mm. Key safety endpoints included major adverse events (MAEs) and symptomatic deep venous thrombosis in the target limb. Effectiveness endpoints included primary patency defined as freedom from ≥50% stenosis, occlusion, or clinically-d…
sj-docx-1-jet-10.1177_15266028211034862 – Supplemental material for Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System
2021
Supplemental material, sj-docx-1-jet-10.1177_15266028211034862 for Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System by Grzegorz Halena, Dainis K. Krievins, Dierk Scheinert, Janis Savlovskis, Piotr Szopiński, Albrecht Krämer, Kenneth Ouriel, Andrej Schmidt, Michal Zdunek and Sean P. Lyden in Journal of Endovascular Therapy
sj-docx-1-jet-10.1177_15266028211034862 – Supplemental material for Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System
2021
Supplemental material, sj-docx-1-jet-10.1177_15266028211034862 for Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System by Grzegorz Halena, Dainis K. Krievins, Dierk Scheinert, Janis Savlovskis, Piotr Szopiński, Albrecht Krämer, Kenneth Ouriel, Andrej Schmidt, Michal Zdunek and Sean P. Lyden in Journal of Endovascular Therapy